average weight loss with glp-1 agonists glp 1 gip triple agonist Retatrutide is a triple-agonist drug targeting GLP- 1, GIP, and Two Years After Stopping GLP-1s,
Description
He added that the scientific community has made significant advancements in the development of more potent medications for diabetes and weight loss
According to the Cleveland Clinic, the higher the dose of the GLP-1 agonist, the more extreme the effects
Furthermore, the study showed that tirzepatide correlated with a marked decrease in the levels of key indicators associated with fibrosis and hypertrophy, such as TGF- , Matrix Metalloprotieinase-9 (MMP9), Collagen Type I Alpha 1 (COLIA1) and F-box only protein 32 (FBXO32) [21]
doi:10.5414/cpp47651 153
